Yeah, this is primarily a review of critical inflammatory conditions, not a cancer paper. Cancer and PD-1 are only mentioned in passing, but on the other hand, the described myeloid lock is the same mechanism that explains PD-1 resistance in tumors.
Traumakine increases IFN from the outside, but similarly, Bex aims to break the lock so that the body’s own IFN response is triggered.
9 Likes